Johnson & Johnson (JNJ) Tops Q3 EPS by 15c; Raises Outlook

October 17, 2023 6:22 AM EDT

Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.66, $0.15 better than the analyst estimate of $2.51. Revenue for the quarter came in at $21.4 billion versus the consensus estimate of $21.04 billion.


Johnson & Johnson sees FY2023 EPS of $10.07-$10.13, versus the consensus of $10.03. Sees Adjusted Operational Sales up 7.2-7.7%, versus prior of 6.2-7.2%.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities